Inflammatory Bowel Diseases

Title Publication Date Language Citations
MicroRNAs in inflammatory bowel disease2012/01/01English101
Determinants of IBD Heritability: Genes, Bugs, and More2018/04/26English101
Occult Hepatitis B and Infliximab-induced HBV Reactivation2007/04/01English101
Enterotoxigenic Bacteroides fragilis: A potential instigator of colitis2007/12/01English101
Linear Growth Improves during Infliximab Therapy in Children with Chronically Active Severe Crohnʼs Disease2007/04/01English100
Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis2008/01/01English100
Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts2012/03/01English100
Mucosal genome-wide methylation changes in inflammatory bowel disease2012/11/01English99
Incidence and Prognosis of Colorectal Dysplasia in Inflammatory Bowel Disease: A Population-based Study from Olmsted County, Minnesota2006/08/01English99
Autoimmune Disorders and Extraintestinal Manifestations in First-degree Familial and Sporadic Inflammatory Bowel Disease2004/05/01English99
Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease2008/07/01English99
Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohnʼs disease2010/01/01English99
Emerging role of hydrogen sulfide in colonic physiology and pathophysiology2011/07/01English99
Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): Methodology and initial results2012/11/01English98
Healing of intestinal inflammation by IL-222012/09/01English98
Incidence and clinical significance of immunogenicity to infliximab in Crohnʼs disease2009/08/01English98
Clostridium difficile Infection in the Inflammatory Bowel Disease Patient2013/01/01English98
Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease2012/02/01English98
Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease2010/08/01English98
Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels2007/06/01English98
Adaptation of Bacteria to the Intestinal Niche: Probiotics and Gut Disorder2001/05/01English98
Profiling adipocytokine secretion from creeping fat in Crohnʼs disease2006/06/01English98
IL-23 receptor (IL-23R) gene protects against pediatric Crohnʼs disease2007/05/01English98
Commensal and Probiotic Bacteria Influence Intestinal Barrier Function and Susceptibility to Colitis in Nod1−/−;Nod2−/− Mice2012/08/01English97
Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohnʼs disease: A prospective pilot study2009/10/01English97
Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation2011/01/01English97
Information needs and preferences of recently diagnosed patients with inflammatory bowel disease2011/02/01English97
Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children2008/03/01English97
Challenges in pediatric inflammatory bowel disease2006/09/01English97
Bacterial Population Analysis of Human Colon and Terminal Ileum Biopsies with 16S rRNA-based Fluorescent Probes: Commensal Bacteria Live in Suspension and Have No Direct Contact with Epithelial Cells2005/10/01English97